0
Abstract: Poster Presentations |

EPIDEMIOLOGY OF RENAL INSUFFICIENCY IN GERIATRIC PATIENTS WITH VENTILATOR-ASSOCIATED PNEUMONIA FREE TO VIEW

Lee E. Morrow, MD, FCCP*; Mark A. Malesker, PharmD; Matt Vanderloo, BS
Author and Funding Information

Creighton University Medical Center, Omaha, NE


Chest


Chest. 2007;132(4_MeetingAbstracts):553a. doi:10.1378/chest.132.4_MeetingAbstracts.553a
Text Size: A A A
Published online

Abstract

PURPOSE: Although renal insufficiency (RI) is a frequent finding in the intensive care (ICU) and is associated with negative outcomes, little is know about its epidemiology in geriatric patients with ventilator associated pneumonia (VAP). Considering the implications for dosing many of the most commonly used ICU medications, the purpose of this project was to elucidate the changes in renal function following the onset of VAP in elderly patients.

METHODS: We prospectively evaluated data from 92 consecutive geriatric patients (age 65 years or more) with VAP diagnosed between 1/1/02 and 12/31/04. Patients with pre-existing renal failure requiring hemodialysis were not included. Data collected included demographics, co-morbid illness, daily laboratory values, antibiotics ordered, and length of stay measures. The Cockroft-Gault equation was used to calculate the creatinine clearance (CrCl) on a daily basis. Patients were classified as having no RI (CrCl > 90 ml/min), mild RI (CrCl 51–90 mL/min), moderate RI (CrCl 10–50 mL/min), or severe RI (CrCl < 10 mL/min). Renal dosing of medications was deemed necessary for patients who had moderate or severe RI.

RESULTS: The cohort was 59% male and had an average age of 71.3 years. Overall, 34% of subjects had RI severe enough to require renal dosage adjustment (CrCl < 50 mL/min) at baseline. This increased to 49% over the 14 days following VAP diagnosis. This is of clinical consequence since recent VAP treatment guidelines focus specifically on appropriate empiric antibiotic choice and appropriate antibiotic dosing.

CONCLUSION: These data demonstrate that: (1) geriatric patients with VAP have high rates of RI at baseline; and (2) these individuals are at risk for worsening renal impairment after initiating therapy.

CLINICAL IMPLICATIONS: This study underscores the need for close monitoring of renal function in geriatric VAP patients in order to appropriately optimize pharmacotherapy.

DISCLOSURE: Lee Morrow, None.

Wednesday, October 24, 2007

12:30 PM - 2:00 PM


Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
Guidelines
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543